Company intelligence / Profile preview

Nue Life Health

Miami Beach, Florida, United Statesnue.life ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Over 60% of treatment-resistant patients experienced a clinically significant reduction in symptoms after six at-home ketamine sessions. The company has completed over 50,000 dosings with strong patient-reported outcomes for depression and anxiety[1].

Therapeutic areas: Psychiatry
Modalities: Small molecule (ketamine)Non-pharmacological therapy (integration support, health coaching)Device (digital app for tracking and integration)
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

ketamine

Commercial

Indications: Treatment-resistant depression, Anxiety, Post-traumatic stress disorder

Partnerships

Field Trip Health & Wellness (psychedelic-assisted psychotherapy provider)WHOOP (human performance company)Institute for Integrative TherapiesMiraminds Holistic Care

Beyond the preview

Go deeper on Nue Life Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nue Life Health.

Explore the full profile